Literature DB >> 17479075

Therapy insight: inborn errors of metabolism in adult neurology--a clinical approach focused on treatable diseases.

Frédéric Sedel1, Olivier Lyon-Caen, Jean-Marie Saudubray.   

Abstract

Inborn errors of metabolism (IEMs) are genetic disorders characterized by dysfunction of an enzyme or other protein involved in cellular metabolism. In most cases, IEMs involve the nervous system. The first clinical symptoms of IEMs usually present in infancy, but in an unknown proportion of cases they can appear in adolescence or adulthood. In this Review, we focus on treatable IEMs, presenting acutely or chronically, that can be diagnosed in an adult neurology department. To make our presentation readily usable by clinicians, the Review is subdivided into eight sections according to the main clinical presentations: emergencies (acute encephalopathies and strokes), movement disorders, peripheral neuropathies, spastic paraparesis, cerebellar ataxia, psychiatric disorders, epilepsy and leukoencephalopathies. Our aim is to present simple guidelines to enable neurologists to avoid overlooking a treatable metabolic disease.

Entities:  

Mesh:

Year:  2007        PMID: 17479075     DOI: 10.1038/ncpneuro0494

Source DB:  PubMed          Journal:  Nat Clin Pract Neurol        ISSN: 1745-834X


  13 in total

1.  A urinary cause of coma.

Authors:  Nicolas Weiss; Charlene Levi; Claire Hussenet; Alexandre Karras; Frederic Sedel; Sophie Espinoza; Magali Savalle; Iris Pelieu; Jean-Yves Fagon; Emmanuel Guerot; Jean-Luc Diehl
Journal:  J Neurol       Date:  2010-12-07       Impact factor: 4.849

2.  Therapeutic interventions in the primary hereditary ataxias.

Authors:  Gonzalo J Revuelta; George R Wilmot
Journal:  Curr Treat Options Neurol       Date:  2010-07       Impact factor: 3.598

Review 3.  Treatable inherited rare movement disorders.

Authors:  H A Jinnah; Alberto Albanese; Kailash P Bhatia; Francisco Cardoso; Gustavo Da Prat; Tom J de Koning; Alberto J Espay; Victor Fung; Pedro J Garcia-Ruiz; Oscar Gershanik; Joseph Jankovic; Ryuji Kaji; Katya Kotschet; Connie Marras; Janis M Miyasaki; Francesca Morgante; Alexander Munchau; Pramod Kumar Pal; Maria C Rodriguez Oroz; Mayela Rodríguez-Violante; Ludger Schöls; Maria Stamelou; Marina Tijssen; Claudia Uribe Roca; Andres de la Cerda; Emilia M Gatto
Journal:  Mov Disord       Date:  2017-09-01       Impact factor: 10.338

Review 4.  Peripheral neuropathy and inborn errors of metabolism in adults.

Authors:  F Sedel; C Barnerias; O Dubourg; I Desguerres; O Lyon-Caen; Jean-Marie Saudubray
Journal:  J Inherit Metab Dis       Date:  2007-09-21       Impact factor: 4.982

Review 5.  Hereditary spastic paraparesis in adults associated with inborn errors of metabolism: a diagnostic approach.

Authors:  F Sedel; B Fontaine; J M Saudubray; O Lyon-Caen
Journal:  J Inherit Metab Dis       Date:  2007-10-22       Impact factor: 4.982

Review 6.  Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults.

Authors:  F Sedel; N Baumann; J-C Turpin; O Lyon-Caen; J-M Saudubray; D Cohen
Journal:  J Inherit Metab Dis       Date:  2007-08-10       Impact factor: 4.982

Review 7.  Psychiatric manifestations in cerebrotendinous xanthomatosis.

Authors:  M J Fraidakis
Journal:  Transl Psychiatry       Date:  2013-09-03       Impact factor: 6.222

Review 8.  Leukoencephalopathies associated with inborn errors of metabolism in adults.

Authors:  F Sedel; A Tourbah; B Fontaine; C Lubetzki; N Baumann; J-M Saudubray; O Lyon-Caen
Journal:  J Inherit Metab Dis       Date:  2008-02-25       Impact factor: 4.750

Review 9.  Movement disorders and inborn errors of metabolism in adults: a diagnostic approach.

Authors:  F Sedel; J-M Saudubray; E Roze; Y Agid; M Vidailhet
Journal:  J Inherit Metab Dis       Date:  2008-05-30       Impact factor: 4.750

10.  Diagnosis, investigation and management of hereditary spastic paraplegias in the era of next-generation sequencing.

Authors:  Anke Hensiek; Stephen Kirker; Evan Reid
Journal:  J Neurol       Date:  2014-12-06       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.